Regarding: 'Explorative study to identify novel candidate genes related to oxaliplatin efficacy and toxicity using a DNA repair array'.
J
J
Pander
H
H
Gelderblom
T
T
van der Straaten
C J A
CJ
Punt
H-J
HJ
Guchelaar
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D064007:Ataxia Telangiectasia Mutated Proteins; D000069287:Capecitabine; D018797:Cell Cycle Proteins / Q000187:drug effects* / Q000235:genetics*; D004260:DNA Repair; D004268:DNA-Binding Proteins / Q000187:drug effects* / Q000235:genetics*; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D004720:Endonucleases / Q000235:genetics*; D005472:Fluorouracil / Q000008:administration & dosage / Q000031:analogs & derivatives; D006801:Humans; D009687:Nuclear Proteins / Q000235:genetics*; D009944:Organoplatinum Compounds / Q000009:adverse effects* / Q000627:therapeutic use*; D000077150:Oxaliplatin; D020641:Polymorphism, Single Nucleotide; D017346:Protein Serine-Threonine Kinases / Q000187:drug effects* / Q000235:genetics*; D014157:Transcription Factors / Q000235:genetics*; D025521:Tumor Suppressor Proteins / Q000187:drug effects* / Q000235:genetics*; D000099250:DNA Excision Repair Protein ERCC-5
D064007:Ataxia Telangiectasia Mutated Proteins; D000069287:Capecitabine; D018797:Cell Cycle Proteins; D004268:DNA-Binding Proteins; D003841:Deoxycytidine; D004720:Endonucleases; D005472:Fluorouracil; D009687:Nuclear Proteins; D009944:Organoplatinum Compounds; D000077150:Oxaliplatin; D017346:Protein Serine-Threonine Kinases; D014157:Transcription Factors; D025521:Tumor Suppressor Proteins; D000099250:DNA Excision Repair Protein ERCC-5; C576324:ATM protein, human